Pacific Biosciences of California (PACB) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
3 Feb, 2026Opening remarks and agenda
The meeting was called to order by the CEO, who outlined the agenda and introduced the board and executive team in attendance.
The agenda included formal proposals, voting, and a Q&A session for stockholders.
Board and executive committee updates
Directors and key executives, including the CFO, Chief People Officer, and General Counsel, were introduced as present.
The Inspector of Election, legal counsel, and the independent auditor from Ernst & Young were also in attendance.
Shareholder proposals
Six proposals were presented: election of Class II directors, ratification of the auditor, advisory vote on executive compensation, amendment to the 2020 Equity Incentive Plan, declassification of the board, and limitation of officer liability.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Pacific Biosciences of California
- Virtual annual meeting to vote on directors, auditor, compensation, and equity plan amendment.PACB
Proxy filing23 Apr 2026 - Proxy covers director elections, auditor ratification, compensation, and equity plan amendment.PACB
Proxy filing23 Apr 2026 - Record consumables growth, margin gains, and $48M asset sale set up for up to 12% growth in 2026.PACB
Q4 202513 Apr 2026 - SPARQ-Nx chemistry and global clinical expansion set the stage for accelerated growth in 2026.PACB
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Clinical expansion, innovation, and margin gains drive growth amid global market shifts.PACB
TD Cowen 45th Annual Healthcare Conference3 Feb 2026 - Q2 revenue fell on weak instrument sales, but consumables rose 24% and cost controls took effect.PACB
Q2 20242 Feb 2026 - Gross margin gains, R&D progress, and strong sales funnel signal a positive outlook.PACB
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Callisto automation delivers high-quality libraries with less labor, cost, and greater scalability.PACB
Status Update19 Jan 2026 - Q3 revenue rose sequentially as new products and debt restructuring set up future growth.PACB
Q3 202415 Jan 2026